At Osprey Health Consulting we constantly keep up to date with emerging trends and new processes, and in some cases further the field of strategic thinking through articles written by our in-house experts.
Bernard Murray of Osprey Health Consulting says that as we emerge from the Covid pandemic, it is important that global planners re-inject strategic rigour into planning, and in particular reinvigorate customer relationships to ensure that robust customer insight underlies that […]
Nick Karachalias PhD of Osprey Health Consulting says that the FDA’s lowering of the regulatory bar in granting conditional approval to Alzheimer’s drug aducanumab comes with many and far-reaching dangers – but also creates opportunity for the best prepared pharma […]
Having worked in the field of future decision making and strategy for many years our team have increasingly recognised the shortcomings of the traditional approach to scenario planning and simulation.
This article is the last in a series of three from Osprey Health Consulting. In this third article we will cover the importance of insight and measurement in brand planning and provide the brand planner with a checklist to assess whether their plan addresses the challenges of the modern pharmaceutical market.
In our first article we addressed the modern challenges to strategic planning; the growing complexity and uncertainty that presents challenges to creating a comprehensive and coherent vision of the future.
This article is the first in a series of three from Osprey Health Consulting that address the contemporary challenges facing strategic brand planners dealing with increasingly complex and uncertain markets.